Potential of Pharmacokinetic Profiling for Detecting Herbal Interactions with Drugs
- 1 January 2008
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 47 (6) , 383-397
- https://doi.org/10.2165/00003088-200847060-00003
Abstract
The issue of herb-drug interactions has generated significant concern within the pharmaceutical industry and among regulatory authorities in recent years. Therefore, accurate models of predicting metabolic herb-drug interactions would be useful tools in efforts to avoid toxic adverse events. However, the majority of pharmacokinetic interactions listed for herbal medicinal products are based on theoretical predictions of the in vitro pharmacological effects of known constituents, which do not necessarily have to be the active ingredients. The prediction of herb-drug interactions is further complicated by the fact that pharmacokinetic data on active or (at least) known ingredients are often not available. The present article discusses the potential of pharmacokinetic profiling for detecting herb-drug interactions, using the most frequently cited interactions in the literature as examples. In particular, common mechanisms of herb-drug interactions are summarized, and the available experimental methods for detecting such interactions, as well as the limitations of these models, are critically evaluated. In addition, we discuss the question of whether the existing methods of detecting herb-drug interactions correlate with the clinical relevance. Effective screening tools that accurately predict metabolic herb-drug interactions would offer a tremendous advantage because it is not possible to study all potential herb-drug interactions in clinical trials.Keywords
This publication has 115 references indexed in Scilit:
- Undesirable Effects of Citrus Juice on the Pharmacokinetics of DrugsDrug Safety, 2005
- Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatinBritish Journal of Clinical Pharmacology, 2004
- Dietary Effects on Drug Metabolism and TransportClinical Pharmacokinetics, 2003
- Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activitiesPhytotherapy Research, 2002
- St John's wort (Hypericum perforatum): drug interactions and clinical outcomesBritish Journal of Clinical Pharmacology, 2002
- Interactions Between Herbal Medicines and Prescribed DrugsDrugs, 2001
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.British Journal of Clinical Pharmacology, 1995